phenytoin has been researched along with Myeloproliferative Disorders in 1 studies
Myeloproliferative Disorders: Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Idiopathic myelofibrosis (IM) is a myeloproliferative syndrome characterized by anemia, fibrosis of the bone marrow, variable proliferation of megakaryocytes, myelocytic and erythrocytic precursors, and splenomegaly." | 1.26 | Extramedullary blast transformation in the central nervous system in idiopathic myelofibrosis. ( Barnes, HM; Prchal, JT; Scott, CW, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, HM | 1 |
| Prchal, JT | 1 |
| Scott, CW | 1 |
1 other study available for phenytoin and Myeloproliferative Disorders
| Article | Year |
|---|---|
Extramedullary blast transformation in the central nervous system in idiopathic myelofibrosis.
Topics: Central Nervous System Diseases; Cerebrospinal Fluid; Dexamethasone; Humans; Male; Methotrexate; Mid | 1981 |